Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.37
- Piotroski Score 7.00
- Grade Buy
- Symbol (PODD)
- Company Insulet Corporation
- Price $230.12
- Changes Percentage (1.02%)
- Change $2.33
- Day Low $227.12
- Day High $231.81
- Year High $243.98
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $280.00
- High Stock Price Target $350.00
- Low Stock Price Target $200.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $3.33
- Trailing P/E Ratio 57.48
- Forward P/E Ratio 57.48
- P/E Growth 57.48
- Net Income $206.30 M
Income Statement
Quarterly
Annual
Latest News of PODD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
Fidelity Investments' "Fidelity Growth Strategies Fund" Q2 2024 investor letter shows a -2.39% return, slightly outperforming the benchmark. Key holdings like Insulet Corporation (NASDAQ:PODD) gained ...
By Yahoo! Finance | 1 week ago -
Insulet's (PODD) Sales And Margins Surpassed Expectations
Brown Capital Management's Mid Company Fund underperformed in Q2 2024, focusing on EGCs with strong growth. Highlighting Insulet Corporation's success, the fund sees potential in AI stocks for higher ...
By Yahoo! Finance | 1 month ago -
Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now
Insulet Corporation (NASDAQ:PODD) is a key player in the diabetes stock market. Despite inventory concerns, its Omnipod devices show strong demand, leading to increased revenue projections. Analysts s...
By Yahoo! Finance | 1 month ago
